Evidence map›Paper›PMID 39436672›Full record

ArticleACS nano2024

Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles.

Kenneth Hulugalla, Oluwaseyi Shofolawe-Bakare, Veeresh B Toragall, Sk Arif Mohammad, Railey Mayatt, Kelsie Hand, Joshua Anderson, Claylee Chism, Sandeep K Misra, Tanveer Shaikh and 5 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Nanosystems for delivery of indolicidin peptide.Frontiers in medical technology · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kenneth HulugallaDepartment of BioMolecular Sciences, University of Mississippi, University, Mississippi 38677, United States.
Oluwaseyi Shofolawe-BakareDepartment of Chemical Engineering, University of Mississippi, University, Mississippi 38677, United States.
Veeresh B ToragallDepartment of Biomedical Engineering, University of Mississippi, University, Mississippi 38677, United States.
Sk Arif MohammadDepartment of Biomedical Engineering, University of Mississippi, University, Mississippi 38677, United States.
Railey MayattDepartment of Chemistry, Mississippi State University, Starkville, Mississippi 39762, United States.
Kelsie HandDepartment of Biomedical Engineering, University of Mississippi, University, Mississippi 38677, United States.
Joshua AndersonDepartment of Biomedical Engineering, University of Mississippi, University, Mississippi 38677, United States.
Claylee ChismDepartment of Chemistry and Biochemistry, University of Mississippi, University, Mississippi 38677, United States.
Sandeep K MisraDepartment of BioMolecular Sciences, University of Mississippi, University, Mississippi 38677, United States.ORCID 0000-0001-9165-3987
Tanveer ShaikhDepartment of Chemistry, Mississippi State University, Starkville, Mississippi 39762, United States.ORCID 0000-0001-9386-7778
Eden E L TannerDepartment of Chemistry and Biochemistry, University of Mississippi, University, Mississippi 38677, United States.ORCID 0000-0002-7919-2249
Adam E SmithDepartment of Biomedical Engineering, University of Mississippi, University, Mississippi 38677, United States.ORCID 0000-0003-1733-443X
Joshua S SharpDepartment of BioMolecular Sciences, University of Mississippi, University, Mississippi 38677, United States.ORCID 0000-0002-0115-0276
Nicholas C FitzkeeDepartment of Chemistry, Mississippi State University, Starkville, Mississippi 39762, United States.ORCID 0000-0002-8993-2140
Thomas WerfelDepartment of BioMolecular Sciences, University of Mississippi, University, Mississippi 38677, United States.ORCID 0000-0002-6005-1243

Funding

Training and Mentoring Core P20GM103476 · NIGMS · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI MICHAEL R GARRETT · 2012 to 2026
$60.2M
Tracking Glycosylation State with Fluorinated Glycosides ProbesP20GM130460 · NIGMS · UNIVERSITY OF MISSISSIPPI · PI Joshua S Sharp · 2020 to 2026
$17.9M
Structure, Orientation, and Competitive Interactions of S. Epidermidis Biofilm Proteins on SurfacesR01AI139479 · NIAID · MISSISSIPPI STATE UNIVERSITY · PI FITZKEE, NICHOLAS C · 2018 to 2022
$1.8M
The Structure, Orientation, and Competitive Interactions of S. Epidermidis Biofilm Proteins on SurfacesR56AI139479 · NIAID · MISSISSIPPI STATE UNIVERSITY · PI FITZKEE, NICHOLAS C · 2024 to 2024
$417k
Laser spectroscopic instrumentation for isotopic sensing of biogenic Nitric OxideR21GM103460 · NIGMS · PRINCETON UNIVERSITY · PI WYSOCKI, GERARD · 2012 to 2012
$190k
NIAID NIH HHS R01 AI139479NIAID NIH HHS R56 AI139479NIGMS NIH HHS P20 GM103476NIGMS NIH HHS P20 GM130460NIGMS NIH HHS R21 GM103460
6 · The paper itself

Abstract

Nanoparticles (NPs) offer significant promise as drug delivery vehicles; however, their

Indexed as

NanoparticlesPolyethylene GlycolsProtein CoronaAnimalsCell Line, TumorDrug Delivery SystemsFemaleHumansMiceMice, Inbred BALB CMononuclear Phagocyte SystemPolymersTissue DistributionPolyethylene GlycolsPolymersProtein CoronaCancer TherapyGlycopolymersNanoparticlesProtein CoronaTargeted Drug Delivery

Identifiers

PMID39436672
PMCPMC12045476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.